Skip to main content

Table 1 Patients characteristics

From: SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial

  Mean ± SD or n/N (%)
Age (years) 60.3 ± 7.6
Female gender 23/58 (39.0)
Body weight (kg) 87.6 ± 13
Height (cm) 171 ± 11
BMI (kg/m2) 29.8 ± 4.3
Mean duration of diabetes (years) 5.54 ± 4.9
HbA1c (%) 6.67 ± 0.7%
Blood glucose concentration
 Fasting (mg/dl) 132 ± 28
 Postprandiala (mg/dl) 178 ± 66
Office blood pressure
 Systolic (mmHg) 130 ± 13
 Diastolic (mmHg) 80 ± 9.4
 Heart rate (bpm) 69 ± 11
24 h ambulatory blood pressure
 Systolic (mmHg) 129 ± 12
 Diastolic (mmHg) 77 ± 9
 Heart rate (bpm) 74 ± 11
Haematocrit (%) 40.1 ± 2.7
Serum sodium concentration (mmol/l) 138.6 ± 2.0
Urinary sodium excretion over 24 h (mmol/day) 216 ± 81
  1. N = 59. BMI body mass index, HbA1c glycated haemoglobin
  2. aA standardised breakfast was given